Beneficial treatment of patients with advanced cancer using a Newcastle disease virus vaccine (MTH-68/H).
about
Genetically engineered Newcastle disease virus for malignant melanoma therapyp53-independent endoplasmic reticulum stress-mediated cytotoxicity of a Newcastle disease virus strain in tumor cell linesApplication of autologous tumor cell vaccine and NDV vaccine in treatment of tumors of digestive tractAn overview on the development of newcastle disease virus as an anti-cancer therapy.Oncolytic viral therapy of malignant gliomaDetection of Newcastle disease virus minor genetic variants by modified single-stranded conformational polymorphism analysis.Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions.Progress in oncolytic virotherapy for the treatment of thyroid malignant neoplasm.Oncolytic Newcastle Disease Virus as Cutting Edge between Tumor and HostTherapeutic potential of oncolytic Newcastle disease virus: a critical review.Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidase.Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL.Inhibitory and apoptosis-inducing effects of Newcastle disease virus strain AF2240 on mammary carcinoma cell line.Designing and building oncolytic viruses.Bird feathers as potential sources of pathogenic microorganisms: a new look at old diseases.New frontiers in oncolytic viruses: optimizing and selecting for virus strains with improved efficacy.In Vitro Synergistic Enhancement of Newcastle Disease Virus to 5-Fluorouracil Cytotoxicity against Tumor Cells.Viral Vectors in Gene Therapy.
P2860
Q24597831-2F76A546-1E6A-4CA0-9667-F990601B30C8Q24672443-8F08CE48-32F5-470D-82BB-CBBB29574505Q36209720-7D141222-58E8-46B4-8C8E-BAE88617D89FQ36568040-E0288375-D98C-46E3-AD9B-D04394B4BE9CQ37533665-28995AA5-1822-401A-B4F6-DD00B96546E2Q37725507-36333712-50C2-48EB-98E9-D63D92B685F7Q37990940-BDF48AD6-BF62-466A-8633-EF7D67EBD30EQ38264652-8C35FBCE-0C07-4D5E-B4A5-78B6F9978A54Q38369289-866A79F3-91F2-45B8-A04F-7A37C6410FB5Q38924554-2C848332-5309-4DBA-9B18-52B269FE462BQ39839714-F3E4FEB7-BC0D-4DB3-8C76-76310AA78D04Q40511505-BB3C3BDF-F87F-4A23-B46B-51C6586DA2F5Q41968249-56F8C175-A3CA-4C5A-8E70-3D49CEE3869DQ47547386-358E2244-F93D-4F92-A951-EAD806E4CAF6Q49824795-9E076CEB-3CAF-498F-8412-62EFE26CC3DBQ50056861-C0AFB6F9-5B22-4A79-B019-F997D5C65B81Q50905634-4F2B5995-C6A2-4BEF-B658-D41540CF688EQ55408780-274DD794-DEAA-4572-950E-BB42EC8C39B7
P2860
Beneficial treatment of patients with advanced cancer using a Newcastle disease virus vaccine (MTH-68/H).
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Beneficial treatment of patien ...... ease virus vaccine (MTH-68/H).
@ast
Beneficial treatment of patien ...... ease virus vaccine (MTH-68/H).
@en
type
label
Beneficial treatment of patien ...... ease virus vaccine (MTH-68/H).
@ast
Beneficial treatment of patien ...... ease virus vaccine (MTH-68/H).
@en
prefLabel
Beneficial treatment of patien ...... ease virus vaccine (MTH-68/H).
@ast
Beneficial treatment of patien ...... ease virus vaccine (MTH-68/H).
@en
P2093
P1433
P1476
Beneficial treatment of patien ...... ease virus vaccine (MTH-68/H).
@en
P2093
P304
P407
P577
1999-01-01T00:00:00Z